Highly Priced Gene Therapies: A Wake-Up Call for Early Price Regulation Feng Xie Commentary 08 May 2018 Pages: 883 - 888
Sensitivity Analysis for Not-at-Random Missing Data in Trial-Based Cost-Effectiveness Analysis: A Tutorial Baptiste LeurentManuel GomesJames R. Carpenter Practical Application Open access 20 April 2018 Pages: 889 - 901
Ponatinib for Treating Chronic Myeloid Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal Abdullah PandorMatt StevensonRuth Wong Review Article 26 February 2018 Pages: 903 - 915
Ixekizumab for Treating Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal Bram L. T. RamaekersRobert F. WolffManuela A. Joore Review Article Open access 26 February 2018 Pages: 917 - 927
Cost Effectiveness of Human Papillomavirus Vaccination for Men Who have Sex with Men; Reviewing the Available Evidence Didik SetiawanAbrham WondimuMaarten J. Postma Systematic Review 20 April 2018 Pages: 929 - 939
Does Non-Adherence Increase Treatment Costs in Schizophrenia? Mark PenningtonPaul McCrone Systematic Review 26 April 2018 Pages: 941 - 955
Cost-Effectiveness of Biological Asthma Treatments: A Systematic Review and Recommendations for Future Economic Evaluations R. Brett McQueenDanielle N. SheehanJonathan D. Campbell Systematic Review 08 May 2018 Pages: 957 - 971
Comparing the Relative Importance of Attributes of Metastatic Renal Cell Carcinoma Treatments to Patients and Physicians in the United States: A Discrete-Choice Experiment Juan Marcos GonzálezJustin DoanMayer Fishman Original Research Article 05 June 2018 Pages: 973 - 986
Applying GRADE Criteria to Clinical Inputs to Cost-Effectiveness Modeling Studies Alexander MenschTanja BeckDirk Müller Original Research Article 28 May 2018 Pages: 987 - 994
Effects of County Public Hospital Reform on Procurement Costs and Volume of Antibiotics: A Quasi-Natural Experiment in Hubei Province, China Yuqing TangChaojie LiuKeyuan Zuo Original Research Article Open access 18 April 2018 Pages: 995 - 1004
Costs of Cancer Care for Elderly Patients with Neuroendocrine Tumors Chan ShenArvind DasariYa-Chen Tina Shih Original Research Article 23 April 2018 Pages: 1005 - 1013
Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK Paul EmeryMarjolijn Van KeepHelena Marzo-Ortega Original Research Article Open access 25 May 2018 Pages: 1015 - 1027
Comment on: “Mapping the Paediatric Quality of Life Inventory (PedsQL™) Generic Core Scales Onto the Child Health Utility Index-9 Dimension (CHU-9D) Score for Economic Evaluation in Children” Emma FrewTosin Lambe Letter to the Editor 20 June 2018 Pages: 1029 - 1029